NCT03133000 is a clinical trial in Incisional Hernia, sponsored by Gross Sand Hospital.

Who is sponsoring NCT03133000?

NCT03133000 is sponsored by Gross Sand Hospital.

What condition does NCT03133000 study?

NCT03133000 studies Incisional Hernia.

Is NCT03133000 still recruiting?

NCT03133000 is currently completed. Last updated 28 April 2017.

Last reviewed 2017-04-28 · How we verify

NCT03133000

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mini- or Less-Open Sublay Operation (MILOS) of Incisional Hernias

Completed Last updated 28 April 2017

What this trial tests

trial in Incisional Hernia in 615 participants. Completed in 30 September 2016.

Timeline

1 January 2010

Primary endpoint
30 September 2015

30 September 2016

Quick facts

Lead sponsor	Gross Sand Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	615
Start date	1 January 2010
Primary completion	30 September 2015
Estimated completion	30 September 2016

Conditions studied

Incisional Hernia — all drugs for Incisional Hernia →

Sponsor

Gross Sand Hospital

Who can join

15 and older, any sex, with Incisional Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective non-randomized observational register study of all elective symptomatic incisional hernias operated on in the Hernia Center of Reference of Gross Sand Hospital using the novel endoscopic assisted Mini- or Less-Open Sublay technique. The data of all patients were prospectively documented in the German Hernia Registry "Herniamed". The novel MILOS-technique allows the minimal invasive implantation of large extraperitoneal meshes for the treatment of primary and secondary incisional hernias.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Mini- or Less-open Sublay Operation (MILOS): A New Minimally Invasive Technique for the Extraperitoneal Mesh Repair of Incisional Hernias.
Reinpold W, Schröder M, Berger C, Nehls J, et al · · 2019 · cited 75× · PMID 29342018 · DOI 10.1097/sla.0000000000002661
Mini- or less-open sublay (E/MILOS) operation vs open sublay and laparoscopic IPOM repair for the treatment of incisional hernias: a registry-based propensity score matched analysis of the 5-year results.
Reinpold W, Berger C, Adolf D, Köckerling F. · · 2024 · cited 6× · PMID 37603090 · DOI 10.1007/s10029-023-02847-3

Verify or expand the search:

Other recruiting trials for Incisional Hernia

Currently open trials in the same condition.

NCT06762561 — Prophylactic Mesh Reinforcement After Open Aortic Aneurysm Repair · recruiting
NCT06499324 — Surgery with Botulinum Toxin a for Incisional Hernia · Phase 3 · recruiting
NCT06220058 — Comparing Polypropylene Mesh and "Small Bites" Technique in Emergency Colorectal Surgery's Midline Laparotomy Closure. S · NA · recruiting
NCT05596357 — Incisional heRnia dIgestion Sexuality · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03133000 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gross Sand Hospital
Last refreshed: 28 April 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03133000.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing